Octreotide 20mg inj vials
BNF presentation 0803043N0AAAGAG within chapter Malignant Disease and Immunosuppression. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
0803043N0AAAGAG
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
90
NHS spend (£)
£69,122.11
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 8 |
| February 2025 | 1 |
| November 2024 | 2 |
| October 2024 | 6 |
| July 2024 | 7 |
| May 2024 | 2 |
| July 2021 | 5 |
| June 2021 | 9 |
| December 2020 | 19 |
| November 2020 | 31 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 3 | No data available |
|
Collingham Medical Centre
ODS C84045
|
3 | 52R - NOTTINGHAM AND NOTTINGHAMSHIRE ICB |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |